Literature DB >> 19013207

Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper.

Viviana Arce-Estrada1, Gabriela Azofeifa-Cordero, Ricardo Estrada, Alberto Alape-Girón, Marietta Flores-Díaz.   

Abstract

In this work, the cDNA encoding a novel P-II type metalloproteinase from Bothrops asper venom glands was cloned, sequenced and used for DNA immunization of animals with accelerated DNA-coated tungsten microparticles and the helius Gene Gun system. Specific antibodies against B. asper venom antigens were induced in mice co-immunized with the plasmid encoding the P-II metalloproteinase together with an expression plasmid encoding the murine IL-2. Similarly, specific antibodies against B. asper venom antigens were also induced in a horse co-immunized with the plasmid encoding the P-II metalloproteinase, together with a plasmid encoding the equine IL-6. The equine antibodies induced by immunization with the P-II metalloproteinase encoding plasmid cross react with several proteins of B. asper, Crotalus durissus durissus, and Lachesis stenophrys venoms in western blot, demonstrating antigenic similarity between the cloned metalloproteinase and other metalloproteinases present in these venoms. Furthermore, the equine antibodies induced by immunization with the P-II metalloproteinase encoding plasmid completely neutralized the hemorrhagic activity of the whole B. asper venom and partially the hemorrhagic activity of C. durissus durissus venom. The neutralizing ability of the produced antibodies raises, for the first time, the possibility of developing therapeutic antivenoms in horses by DNA immunization using tungsten microparticles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013207     DOI: 10.1016/j.vaccine.2008.10.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Animal venom studies: Current benefits and future developments.

Authors:  Yuri N Utkin
Journal:  World J Biol Chem       Date:  2015-05-26

2.  Computer-Aided Analysis of West Sub-Saharan Africa Snakes Venom towards the Design of Epitope-Based Poly-Specific Antivenoms.

Authors:  Albert Ros-Lucas; Pascal Bigey; Jean-Philippe Chippaux; Joaquim Gascón; Julio Alonso-Padilla
Journal:  Toxins (Basel)       Date:  2022-06-18       Impact factor: 5.075

3.  Therapeutic application of natural inhibitors against snake venom phospholipase A(2).

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone; Vincent Tk Chow
Journal:  Bioinformation       Date:  2012-01-06

4.  High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays.

Authors:  Mikael Engmark; Mikael R Andersen; Andreas H Laustsen; Jigar Patel; Eric Sullivan; Federico de Masi; Christian S Hansen; Jens V Kringelum; Bruno Lomonte; José María Gutiérrez; Ole Lund
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

Review 5.  Innovative Immunization Strategies for Antivenom Development.

Authors:  Erick Bermúdez-Méndez; Albert Fuglsang-Madsen; Sofie Føns; Bruno Lomonte; José María Gutiérrez; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2018-11-02       Impact factor: 4.546

6.  A Heterologous Multiepitope DNA Prime/Recombinant Protein Boost Immunisation Strategy for the Development of an Antiserum against Micrurus corallinus (Coral Snake) Venom.

Authors:  Henrique Roman Ramos; Inácio de Loiola M Junqueira-de-Azevedo; Juliana Branco Novo; Karen Castro; Clara Guerra Duarte; Ricardo A Machado-de-Ávila; Carlos Chavez-Olortegui; Paulo Lee Ho
Journal:  PLoS Negl Trop Dis       Date:  2016-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.